Actively Recruiting
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
Led by Glendale Adventist Medical Center d/b/a Adventist Health Glendale · Updated on 2023-03-03
30
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
G
Glendale Adventist Medical Center d/b/a Adventist Health Glendale
Lead Sponsor
H
Helen Rey Breast Cancer Research Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Cryoablation or tumor freezing is a percutaneous, office-based procedure that is emerging as a minimally invasive, cost-effective alternative to surgery that is currently being evaluated in clinical trials for the management of for early-stage invasive breast cancer. The investigator will also evaluate the potential of cryoablation as a minimally invasive alternative to surgery for small areas of DCIS by examining its ability to achieve complete ablation of DCIS within the targeted cryoablation zone of necrosis.
CONDITIONS
Official Title
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
Who Can Participate
Eligibility Criteria
You may qualify if you...
- DCIS spanning 2 cm or less based on radiographic appearance by mammography and/or breast contrast-enhanced MRI
- Diagnosis of DCIS by minimally invasive needle biopsy
- No prior history of DCIS or invasive breast cancer in the same breast
- No history of surgical biopsy and/or lumpectomy for diagnosis or treatment in the same breast
- Adequate breast volume and skin clearance to permit cryoablation as assessed by Dr. Holmes
- Non-pregnant, non-lactating, and no history of pregnancy within the preceding 6 months
- No history of breast radiation in the same breast
You will not qualify if you...
- Male or females with breasts too small to allow safe cryoablation
- Pregnancy or lactation
- History of pregnancy within the last 6 months
- History of breast radiation in the same breast
- Prior surgical biopsy or lumpectomy in the same breast
- Prior history of DCIS or invasive breast cancer in the same breast
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Office of Dennis R. Holmes, M.D., F.A.C.S.
Glendale, California, United States, 91206
Actively Recruiting
Research Team
D
Dennis R Holmes, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here